A quantitative structure-activity relationship study on serotonin 5-HT₆ receptor ligands: indolyl and piperidinyl sulphonamides

References

• Slassi , A , Isaac , M and O’Brien , A . 2002 . Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases . Expert Opin. Ther. Pat. , 12 : 513 – 527 .
   Web of Science ®Google Scholar
• Hoyer , D and Martin , GR . 1997 . 5-HT receptor classification and nomenclature: towards a harmonization with the human genome . Neuropharmacology , 36 : 419 – 428 .
   PubMed Web of Science ®Google Scholar
• Hoyer , D , Clarke , DE , Fozard , JR , Hartig , PR , Martin , GR , Mylecharane , E , Saxena , PR and Humphrey , PPA . 1994 . International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) . Pharmacol. Rev. , 46 : 157 – 204 .
   PubMed Web of Science ®Google Scholar
• Kohen , R , Metcalf , MA , Khan , N , Druck , T , Huebner , K , Lachowicz , JE , Meltzer , HY , Sibley , DR , Roth , BL and Hamblin , MW . 1996 . Cloning . , characterization, and chromosomal localization of a human 5-HT₆ serotonin receptor, J. Neurochem. , 66 : 47 – 56 .
   Google Scholar
• Ruat , M , Traiffort , E , Arrang , J-M , Tardivel-Lacombe , J , Diaz , J , Leurs , R and Swartz , J-C . 1993 . A novel serotonin (5-HT6) receptor: molecular cloning, localisation and stimulation of cAMP accumulation . Biochem. Biophys. Res. Commun. , 193 : 269 – 276 .
   Web of Science ®Google Scholar
• Sebben , M , Ansanay , H , Bockaert , J and Dumuis , A . 1994 . 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture . Neuroreport , 5 : 2553 – 2557 .
   PubMed Web of Science ®Google Scholar
• Dawson , LA , Nguyen , HQ and Li , P . 2000 . In vivo effects of the 5-HT6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate . British J. Pharmacol. , 130 : 23 – 26 .
   PubMed Web of Science ®Google Scholar
• Dawson , LA , Nguyen , HQ and Li , P . 2001 . The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus . Neuropsychopharmacology , 25 : 662 – 668 .
   PubMed Web of Science ®Google Scholar
• Dawson , LA , Nguyen , HQ and Li , P . 2003 . Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist . Brain Res. Bull. , 59 : 513 – 521 .
   Google Scholar
• Lacroix , LP , Dawson , LA , Hagan , JJ and Heidbreder , CA . 2004 . 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex . Synapse , 51 : 158 – 164 .
   PubMed Web of Science ®Google Scholar
• Riemer , C , Borroni , E , Levet-Trafit , B , Martin , JR , Poli , S , Porter , RH and Bös , M . 2003 . Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist . J. Med. Chem. , 46 : 1273 – 1276 .
   PubMed Web of Science ®Google Scholar
• Healy , DJ and Meador-Woodruff , JH . 1999 . Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain . Neuropsychopharmacology , 21 : 341 – 351 .
   Google Scholar
• Minabe , Y , Shirayama , Y , Hashimoto , K , Routledge , C , Hagan , JJ and Ashby Jr. , CR . 2004 . Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study . Synapse , 52 : 20 – 28 .
   PubMed Web of Science ®Google Scholar
• Roth , BL , Craigo , SC , Choudhary , MS , Uluer , A , Monsma , FJ Jr , Shen , Y , Meltzer , HY and Sibley , DR . 1994 . Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors . J. Pharmacol. Exp. Ther. , 268 : 1403 – 1410 .
   PubMed Web of Science ®Google Scholar
• Monsma , FJ , Shen , Y , Ward , RP , Hamblin , MW and Sibley , DR . 1993 . Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs . Mol. Pharmacol. , 43 : 320 – 327 .
   PubMed Web of Science ®Google Scholar
• Shinkai , T , Ohmori , O , Kojima , H , Terao , T , Suzuki , T and Abe , K . 1999 . Association study of the 5-HT6 receptor gene in schizophrenia . Amer. J. Med. Genet. , 88 : 120 – 122 .
   PubMed Web of Science ®Google Scholar
• Tsai , SJ , Chiu , HJ , Wang , YC and Hong , CJ . 1999 . Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior . Neurosci. Lett. , 271 : 135 – 137 .
   PubMed Web of Science ®Google Scholar
• Vogt , IR , Shimron-Abarbanell , D , Neidt , H , Erdmann , J , Cichon , S , Schulze , TG , Müller , DJ , Maier , W , Albus , M , Borrmann-Hassenbach , M , Knapp , M , Rietschel , M , Propping , P and Nothen , MM . 2000 . Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia . Amer. J. Med. Genet. , 96 : 217 – 221 .
   PubMed Web of Science ®Google Scholar
• Ohmori , O , Shinkai , T , Hori , H and Nakamura , J . 2001 . Novel polymorphism in the 5Â-upstream region of the human 5-HT6 receptor gene and schizophrenia . Neurosci. Lett. , 310 : 17 – 20 .
   PubMed Web of Science ®Google Scholar
• East , SZ , Burnet , PW , Leslie , RA , Roberts , JC and Harrison , PJ . 2002 . 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125 I]SB-258585 . Synapse , 45 : 191 – 199 .
   PubMed Web of Science ®Google Scholar
• Wu , WH , Huo , SJ , Cheng , CY , Hong , CJ and Tsai , SJ . 2001 . Association study of the 5-HT6 receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders . Neuropsychobiology , 44 : 172 – 175 .
   PubMed Web of Science ®Google Scholar
• Messina , D , Annesi , G , Serra , P , Nicoletti , G , Pasqua , A , Annesi , F , Tomaino , C , Ciro-Candiano , IC , Carrideo , S , Caracciolo , M , Spadafora , P , Zappia , M , Savettieri , G and Quattrone , A . 2002 . Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease . Neurology , 58 : 828 – 829 .
   PubMed Web of Science ®Google Scholar
• Thome , J , Retz , W , Baader , M , Pesold , B , Hu , M , Cowen , M , Durany , N , Adler , G , Henn , FA and Rosler , M . 2001 . Association analysis of HTR6 and HTR2A polymorphisms in Sporadic Alzheimer's disease . J. Neural Transm. , 108 : 1175 – 1180 .
   PubMed Web of Science ®Google Scholar
• Liu , HC , Hong , CJ , Liu , CY , Lin , KN , Tsai , SJ , Liu , TY , Chi , CW and Wang , PN . 2001 . Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease . Psychiatry Clin. Neurosci. , 55 : 427 – 429 .
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza , M , Hirst , WD , Chen , CP , Laheras , B , Francis , PT and Ramirez , MJ . 2004 . Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and noncognitive symptoms in Alzheimer's disease . Neuropsychopharmacology , 29 : 410 – 416 .
   PubMed Web of Science ®Google Scholar
• Sleight , AJ , Böss , FG , Bös , M , Levet-Trafit , B , Riemer , C and Bourson , A . 1998 . Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors . British J. Pharmacol. , 124 : 556 – 562 .
   PubMed Web of Science ®Google Scholar
• Bromidge , SM , Brown , AM , Clarke , SE , Dodgson , K , Gager , T , Grassam , HL , Jeffrey , PM , Joiner , GF , King , FD , Middlemiss , DN , Moss , SF , Newman , H , Riley , G , Routledge , C and Wyman , P . 1999 . 5-Chloro-N-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist . J. Med. Chem. , 42 : 202 – 205 .
   PubMed Web of Science ®Google Scholar
• Glennon , RA , Lee , M , Rangisetty , JB , Dukat , M , Roth , BL , Savage , JE , McBride , A , Rauser , L , Hufeisen , L and Lee , DKH . 2000 . 2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors . J. Med. Chem. , 43 : 1011 – 1018 .
   PubMed Web of Science ®Google Scholar
• Russell , MGN , Baker , RJ , Barden , L , Beer , MS , Bristow , L , Broughton , HB , Knowles , M , McAllister , G , Patel , S and Castro , JL . 2001 . N-Arylsulfonylindole derivatives as serotonin 5-HT6 receptor ligands . J. Med. Chem. , 44 : 3881 – 3895 .
   PubMed Web of Science ®Google Scholar
• Holenz , J , Mercè , R , Díaz , JL , Guitart , X , Codony , X , Dordal , A , Romero , G , Torrens , A , Mas , J , Andaluz , B , Hernández , S , Monroy , X , Sánchez , E , Hernández , E , Pérez , R , Cubí , R , Sanfeliu , O and Buschmann , H . 2005 . Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands . J. Med. Chem. , 48 : 1781 – 1795 .
   PubMed Web of Science ®Google Scholar
• Torrens , A , Mas , J , Dordal , A and Fisas , MA . Compuestos sulfonamı′dicos derivados de benzoxazinona, supreparación y uso como medicamentos. Spanish Patent Application ES 2003-01812, July 30, 2003
   Google Scholar
• Todeschini , R , Lasagni , M and Marengo , E . 1994 . New molecular descriptors for 2D and 3D structures theory: Part 1 . J. Chemometrics , 8 : 263 – 272 .
   Web of Science ®Google Scholar
• Galvez , J , Garcia-Domenech , R , de Julian-Ortiz , JV and Soler , R . 1995 . Topological approach to drug design . J. Chem. Inf. Comput. Sci. , 35 : 272 – 284 .
   PubMedGoogle Scholar
• Devillers , J and Balaban , AT . Topological Indices and Related Descriptors in QSAR and QSPR, Gordon and Breach Science Publishers, Singapore,1999, p. 296
   Google Scholar
• Gozalbes , R , Doucet , JP and Derouin , F . 2002 . Application of topological descriptors on QSAR and drug design: history and new trends . Curr. Drug Targets Infect. Disord. , 2 : 93 – 102 .
   PubMedGoogle Scholar
• González , MP , Terán , C , Teijeira , M , Besada , P and González-Moa , MJ . 2005 . BCUT descriptors to predicting affinity toward A3 adenosine receptors . Bioorg. Med. Chem. Lett. , 15 : 3491 – 3495 .
   Google Scholar
• Bagchi , MC , Mills , D and Basak , SC . 2007 . Quantitative structure–activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. megmatis using theoretical molecular descriptors . J. Mol. Model. , 13 : 111 – 120 .
   PubMed Web of Science ®Google Scholar
• Saíz-Urra , L , González , MP and Teijeira , M . 2007 . 2D-autocorrelation descriptors for predicting cytotoxicity of naphthoquinone ester derivatives against oral human epidermoid carcinoma . Bioorg. Med. Chem. , 15 : 3565 – 3571 .
   PubMed Web of Science ®Google Scholar
• Helguera , AM , Combes , RD , González , MP and Cordeiro , MN . 2008 . Applications of 2D descriptors in drug design: a DRAGON tale . Curr. Top. Med. Chem. , 8 : 1628 – 1655 .
   PubMed Web of Science ®Google Scholar
• Kühne , R , Ebert , R-U and Schüürmann , G . 2009 . Chemical domain of QSAR models from atom-centered fragments . J. Chem. Inf. Model. , 49 : 2660 – 2669 .
   PubMed Web of Science ®Google Scholar
• Todeschini , R and Consonni , V . DRAGON software (version 1.11-2001), Milan, Italy
   Google Scholar
• Roth , BL , Craigo , SC , Choudhary , MS , Uluer , A , Monsma , FJ Jr , Shen , Y , Meltzer , HY and Sibley , DR . 1994 . Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors . J. Pharmacol. Exp. Ther. , 268 : 1403 – 1410 .
   PubMed Web of Science ®Google Scholar
• Munson , PJ and Robbard , D . 1980 . LIGAND: A versatile . computerized approach for characterization of ligand-binding systems, Anal. Biochem. , 107 : 220 – 239 .
   Google Scholar
• Chemdraw Ultra 6.0 and Chem3D Ultra, Cambridge Soft Corporation, Cambridge, USA
   Google Scholar
• Prabhakar , YS . 2003 . A combinatorial approach to the variable selection in multiple linearregression: analysis of Selwood et al. data set – a case study . QSAR Comb. Sci. , 22 : 583 – 595 .
   Google Scholar
• Wold , S . 1978 . Cross-validatory estimation of the number of components in factor and principal components models . Technometrics , 20 : 397 – 405 .
   Web of Science ®Google Scholar
• Kettaneh , N , Berglund , A and Wold , S . 2005 . PCA and PLS with very large data sets . Comput. Statist. Data Anal. , 48 : 69 – 85 .
   Web of Science ®Google Scholar
• Stahle , L and Wold , S . 1998 . “ Multivariate data analysis and experimental design ” . In Biomedical Research, Progress in Medicinal Chemistry , Edited by: Ellis , GP and West , WB . Vol. 25 , 291 – 338 . BV, The Netherlands : Elsevier Science Publishers .
   Google Scholar
• Sharma , S , Prabhakar , YS , Singh , P and Sharma , BK . 2008 . QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach . European J. Med. Chem. , 43 : 2354 – 2360 .
   PubMedGoogle Scholar
• Sharma , S , Sharma , BK , Sharma , SK , Singh , P and Prabhakar , YS . 2009 . Topological descriptors in modeling the agonistic activity of human A3 adenosine receptor ligands: the derivatives of 2-chloro-N6-substituted-4′-thioadenosine-5′-uronamide . European J. Med. Chem. , 44 : 1377 – 1382 .
   PubMedGoogle Scholar
• Singh , P , Kumar , R , Sharma , BK and Prabhakar , YS . 2009 . Topological descriptors in modeling malonyl coenzyme A decarboxylase inhibitory activity: N-Alkyl-N(1,1,1,3,3,3-Hexafluoro-2-hydroxypropylphenyl)amide derivatives . J. Enzyme Inhib. Med. Chem. , 24 : 77 – 85 .
   PubMed Web of Science ®Google Scholar
• Sharma , BK , Sharma , SK , Singh , P , Sharma , S and Prabhakar , YS . 2009 . Modeling of vascular endothelial growth factor receptor 2 (VEGFR2) kinase inhibitory activity of 2-Anilino-5-aryloxazoles using chemometric tools . J. Enzyme Inhib. Med. Chem. , 24 : 86 – 93 .
   PubMed Web of Science ®Google Scholar
• Sharma , BK , Pilania , P , Sarbhai , K , Singh , P and Prabhakar , YS . @Chemometric descriptors in modeling the carbonic anhydrase inhibition activity of sulfonamide and sulfamate derivatives, Mol. Divers. 14 (2010), pp. 371–384
   Google Scholar
• So , S-S and Karplus , M . 1997 . Three-dimensional quantitative structure-activity relationship from molecular similarity matrices and genetic neural networks. 1. Method and validation . J. Med. Chem. , 40 : 4347 – 4359 .
   PubMed Web of Science ®Google Scholar
• Prabhakar , YS , Solomon , VR , Rawal , RK , Gupta , MK and Katti , SB . 2004 . CP-MLR/PLS directed structure–activity modeling of the HIV-1 RT inhibitory activity of 2,3-Diaryl- 1,3-thiazolidin-4-ones . QSAR Comb. Sci. , 23 : 234 – 244 .
   Google Scholar
• Akaike , H . 1973 . “ Information theory and an extension of the minimum likelihood principle ” . In Second International Symposium On Information Theory , Edited by: Petrov , BN and Csaki , F . 267 – 281 . Budapest : Akademiai Kiado .
   Google Scholar
• Akaike , H . 1974 . A new look at the statistical identification model . IEEE Trans. Automat. Control AC-19 , : 716 – 723 .
   Google Scholar
• Kubinyi , H . 1994 . Variable selection in QSAR studies. I. An evolutionary algorithm . Quant. Struct.–Act. Relat. , 13 : 285 – 294 .
   Google Scholar
• Kubinyi , H . 1994 . Variable selection in QSAR studies. II. A highly efficient combination of systematic search and evolution . Quant. Struct.-Act. Relat. , 13 : 393 – 401 .
   Google Scholar
• Friedman , J . Multivariate adoptive regression splines, in Technical Report No. 102, Laboratory for Computational Statistics, Department of Statistics, Stanford University, Stanford, USA, November 1988 (revised August 1990)
   Google Scholar
• Hawkins , DM , Basak , SC and Mills , D . 2003 . Assessing model fit by cross-validation . J.Chem. Inf. Comput. Sci. , 43 : 579 – 586 .
   PubMedGoogle Scholar
• Gramatica , P . 2007 . Principles of QSAR models validation: internal and external . QSAR Comb. Sci. , 26 : 694 – 701 .
   Google Scholar
• Lipnick , RL . 1991 . Outliers: their origin and use in the classification of molecular mechanisms of toxicity . Sci. Total Environ. , 109 : 131 – 153 .
   PubMed Web of Science ®Google Scholar